Printer Friendly

Articles from BIOTECH Patent News (September 1, 2005)

1-29 out of 29 article(s)
Title Author Type Words
ABAXIS announces licensing of lyophilization technology to Cepheid. 573
Appeals court affirms summary judgment in favor of Gen-Probe in Enzo patent lawsuit. 266
BioGenex obtains favorable patent ruling against Ventana. 607
CalbaTech advisory member contributes stem cell intellectual property, ranging from banking of stem cells to regeneration of tissues. 438
Cambridge Antibody reports recent progress in licensed product candidates. 524
Chemokine expands protection of core anti-cancer technology with issuance of new United States patent. 514
Chromos enters into license agreement with Becton Dickinson for T-cell expansion patents. 389
Cornell obtains United States patent. Brief Article 125
du Pont obtains United States patent. 85
Focus Diagnostics licenses coronavirus CoV-NL63 from Primagen. 482
Forest Laboratories and Lundbeck enter into settlement agreement with Alphapharm related to Lexapro patent litigation. 488
Genentech provides information on Cabilly patent reexamination. 237
Genetic mutations in brain tumors identified by scientists from Venter Institute, Ludwig Institute, and Johns Hopkins. 554
Human Genome Sciences obtains United States patent. 88
Human Genome Sciences obtains United States patent. 80
IMCOR, Alliance, Molecular Biosystems, and GE Healthcare enter into cross-licensing agreement for ultrasound contrast patents. 366
Intermune issued of two composition of matter patents for Actimmune. 289
Isis expects to earn initial payments of nearly $4 million from Alnylam's recent RNAi collaboration. 738
Jury decision reached in BrainLAB patent infringement lawsuit. 457
Novo Nordisk sues Sanofi-Aventis for insulin delivery device patent infringement. 420
Oncolytics issued Canadian reovirus patent. 256
Power3 Medical files provisional patent application for biomarker-based method to diagnose Alzheimer's Disease. 471
Rib-X granted key antibiotic drug discovery patents. 816
Saliva Diagnostic receives favorable ruling in patent infringement litigation with Chembio Diagnostic Systems. 233
Semafore awarded patent covering PI3K prodrug technology targeting central cell signaling pathway. 897
Signet's monoclonal prion antibody 6D11 available. 309
Sirna granted patent covering RNAi-mediated inhibition of gene expression. 1071
Sirna granted patent covering siRNAs targeting Huntington's Disease. 1128
Vaccine development company receives European patent allowance for enhanced immune response. 292

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters